Lapatinib for treating breast cancer brain metastases
EP1802621A1
Crf receptor antagonists and methods relating thereto
EP1802617A2
Cancer treatment method
MXPA06013952A
Cancer treatment method.
WO2005120504A2
Cancer treatment method
CN1989112A
Cancer treatment method
CN1938309A
CRF receptor antagonists and methods relating thereto
EP1686967A2
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
TW200530250A
Crystalline topotecan hydrochloride product and preparation thereof